Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Tislelizumab × sintilimab × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 7 Carcinoma, Hepatocellular 4 Advanced Solid Tumors 3 Advanced Lung Cancer 2 Tislelizumab 1 Stomach Neoplasms 1 Solid Tumor 1 SCLC 1 Ovarian Neoplasms 1 Osteosarcoma 1 Neoplasm Metastasis 1 Meningeal Carcinomatosis 1 High-Risk Resectable NSCLC 1 Colorectal Neoplasms 1 Advanced/Metastatic Solid Malignancies 1 Advanced or Metastatic Solid Tumors 1 Advanced Solid Tumor 1 Advanced Non-Small Cell Lung Cancer 1 Adenocarcinoma of Lung 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04906044 2023-11-18

STARS-RC03

The First Hospital of Jilin University

Phase 1 Active not recruiting

Gastrointestinal

Tislelizumab

Data powered by HemOnc (CC BY 4.0) Colophon ⚡